Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the best biotech stocks to invest in now. On June 20, Madrigal Pharmaceuticals moved closer to introducing the first treatment for metabolic ...
Wegovy has been approved for use among the growing number of Americans who have MASH. By Dani Blum The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly ...
Please provide your email address to receive an email when new articles are posted on . Experts recommend confirming MASH diagnosis by assessing steatosis via ultrasound or FibroScan. MRI-proton ...
The “MASH” community is pouring one out for actor Eileen Saki, who died Monday at age 79. Saki, who was the last actor to portray Rosie’s Bar boss Rosie on the long-running Korean War series, died ...
Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 metabolic dysfunction-associated steatohepatitis (MASH) study, while still ...
There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...
The FDA is considering using a noninvasive liver measurement as a surrogate endpoint for certain metabolic dysfunction-associated steatohepatitis (MASH) patients, a move that could speed up drug ...
SAN MATEO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback